Thursday, 30 May 2024

 

 

LATEST NEWS Sukhbir Singh Badal Headed a massive road show in the holy city which broke all previous records Anurag Thakur exhorts people to vote for BJP for strong leadership, stable governance & foolproof national security Modi has brought Ram to Ayodhya now it is our duty to bring back Modi: Manoj Tiwari Two independent candidates extend support to Tandon Yuva Morcha holds protest on Swati Maliwal case Tandon gets big boost as Sehajdhari Sikhs to support BJP in Chandigarh and Himachal Pradesh Achhe din aane wale hain, Modi ji jane wale hain: Arvind Kejriwal in Chandigarh BJP’s formidable election machine is set to sweep aside Tewari on June 1: Sanjay Tandon Surveys are here, people have decided, AAP is winning by 13-0: Bhagwant Mann People of Punjab will reply to Amit Shah's threat on June 1, will get BJP's security deposits forfeited : Arvind Kejriwal For the first time, in the AAP govt youth is getting govt jobs in Punjab without any recommendation and bribe : Arvind Kejriwal When the people of Punjab did not bow down to Nadir Shah, then who is Amit Shah: Sanjay Singh Won’t let the peace of Punjab be disturbed at any cost : Sukhbir Singh Badal Rahul Gandhi announces loan waiver for farmers; legal guarantee on MSP Congress will not bring back good days but the old days : Gurjeet Singh Aujla Gurjeet Singh Aujla remembers Sidhu Moosewala Sidhu Moosewala Would have been with us if Punjab Govt. Controlled Crime : Vijay Inder Singla Warring gets further boost; BJP runner up from Ludhiana South Satha joins Congress Preparations for the Lok Sabha elections are complete, Voter are invited to participate in the festival of democracy on June 1 with enthusiasm - Deputy Commissioner Akali Dal chief, secretary and BC wing president join Congress Mann's appeal to the people of Anandpur Sahib: Now instead of swords, we are fighting against injustice and oppression with our votes, support us

 

DRDO's anti-Covid drug 2-DG launched

Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Covid-19 Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Covifor, Oxygen supply, DRDO, Defence Research and Development Organisation
Listen to this article

Web Admin

Web Admin

5 Dariya News

New Delhi , 17 May 2021

The first batch of DRDO-developed anti-Covid drug 2-DG (2-deoxy-D-glucose) was launched on Monday to treat patients suffering from the deadly disease. The medicine comes in powder form and can be taken with water.Defence Minister Rajnath Singh and Health Minister Harsh Vardhan released the first batch of the 2-DG, an anti-Covid-19 therapeutic application of the drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy's Laboratories (DRL).Rajnath Singh handed over the anti-Covid drug to his cabinet colleague Harsh Vardhan who handed over it to Delhi All India Institute of Medical Sciences (AIIMS) director Randeep Guleria at an event here.The Defence Minister would be later distributing around 10,000 doses of the drug to a few hospitals in the national capital.The Drugs Controller General of India (DCGI) granted emergency use nod for the drug last week. The drug could be a game-changer in the battle against pandemic as it helps in faster recovery of hospitalised patients and reduces oxygen dependence.

Clinical trial results have shown that the drug helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients.The medicine was found to be safe for Covid-19 patients in phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.During the first wave of the pandemic in April last year, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth.Based on these results, the Drugs Controller General of India (DCGI) Central Drugs Standard Control Organisation (CDSCO) permitted Phase-II clinical trial of 2- DG in Covid-19 patients in May 2020. The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in Covid-19 patients.In Phase-II trials (including dose ranging) conducted during May-October 2020, the drug was found to be safe in Covid-19 patients and showed significant improvement in their recovery. Phase-II was conducted in six hospitals and Phase IIb (dose ranging) clinical trial was conducted at 11 hospitals all over the country. Phase-II trial was conducted on 110 patients.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Covid-19 Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Covifor , Oxygen supply , DRDO , Defence Research and Development Organisation

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD